3-methylcholanthrene and pd 123319

3-methylcholanthrene has been researched along with pd 123319 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chalopin, M; Clere, N; Coqueret, O; Corre, I; Delneste, Y; Faure, S; Guihot, AL; Hein, L; Henrion, D; Morel, A; Paris, F; Vessières, E	1

Other Studies

1 other study(ies) available for 3-methylcholanthrene and pd 123319

Article	Year
Deficiency or blockade of angiotensin II type 2 receptor delays tumorigenesis by inhibiting malignant cell proliferation and angiogenesis. International journal of cancer, 2010, Nov-15, Volume: 127, Issue:10 Topics: Angiotensin II Type 2 Receptor Blockers; Animals; Carcinoma, Lewis Lung; Cell Growth Processes; Cell Transformation, Neoplastic; Female; Fibrosarcoma; Gene Deletion; Imidazoles; Methylcholanthrene; Mice; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Pathologic; Pyridines; Receptor, Angiotensin, Type 2; Reverse Transcriptase Polymerase Chain Reaction	2010

Article

Year

Deficiency or blockade of angiotensin II type 2 receptor delays tumorigenesis by inhibiting malignant cell proliferation and angiogenesis.

International journal of cancer, 2010, Nov-15, Volume: 127, Issue:10

Topics: Angiotensin II Type 2 Receptor Blockers; Animals; Carcinoma, Lewis Lung; Cell Growth Processes; Cell Transformation, Neoplastic; Female; Fibrosarcoma; Gene Deletion; Imidazoles; Methylcholanthrene; Mice; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Pathologic; Pyridines; Receptor, Angiotensin, Type 2; Reverse Transcriptase Polymerase Chain Reaction

2010